Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Assessment of Gender-Affirming Hormone Therapy Requirements.

Fernandez JD, Kendjorsky K, Narla A, Villasante-Tezanos AG, Tannock LR.

LGBT Health. 2019 Feb 27. doi: 10.1089/lgbt.2018.0116. [Epub ahead of print]

PMID:
30810452
2.

The Genetic Landscape of Diamond-Blackfan Anemia.

Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O'Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O'Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT.

Am J Hum Genet. 2019 Feb 7;104(2):356. doi: 10.1016/j.ajhg.2018.12.011. No abstract available.

3.

The Genetic Landscape of Diamond-Blackfan Anemia.

Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, Handsaker RE, Abdulhay NJ, Fiorini C, Genovese G, Lim ET, Cheng A, Cummings BB, Chao KR, Beggs AH, Genetti CA, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Vlachos A, Lipton JM, Atsidaftos E, Glader B, Narla A, Gleizes PE, O'Donohue MF, Montel-Lehry N, Amor DJ, McCarroll SA, O'Donnell-Luria AH, Gupta N, Gabriel SB, MacArthur DG, Lander ES, Lek M, Da Costa L, Nathan DG, Korostelev AA, Do R, Sankaran VG, Gazda HT.

Am J Hum Genet. 2018 Dec 6;103(6):930-947. doi: 10.1016/j.ajhg.2018.10.027. Epub 2018 Nov 29. Erratum in: Am J Hum Genet. 2019 Feb 7;104(2):356.

PMID:
30503522
4.

Automated Classification of Skin Lesions: From Pixels to Practice.

Narla A, Kuprel B, Sarin K, Novoa R, Ko J.

J Invest Dermatol. 2018 Oct;138(10):2108-2110. doi: 10.1016/j.jid.2018.06.175.

PMID:
30244720
5.

An update on the pathogenesis and diagnosis of Diamond-Blackfan anemia.

Da Costa L, Narla A, Mohandas N.

F1000Res. 2018 Aug 29;7. pii: F1000 Faculty Rev-1350. doi: 10.12688/f1000research.15542.1. eCollection 2018. Review.

6.

Erythropoiesis: insights into pathophysiology and treatments in 2017.

Zivot A, Lipton JM, Narla A, Blanc L.

Mol Med. 2018 Mar 23;24(1):11. doi: 10.1186/s10020-018-0011-z. Review.

7.

Deterministic Remote Entanglement of Superconducting Circuits through Microwave Two-Photon Transitions.

Campagne-Ibarcq P, Zalys-Geller E, Narla A, Shankar S, Reinhold P, Burkhart L, Axline C, Pfaff W, Frunzio L, Schoelkopf RJ, Devoret MH.

Phys Rev Lett. 2018 May 18;120(20):200501. doi: 10.1103/PhysRevLett.120.200501.

PMID:
29864347
8.

The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70.

Gastou M, Rio S, Dussiot M, Karboul N, Moniz H, Leblanc T, Sevin M, Gonin P, Larghéro J, Garrido C, Narla A, Mohandas N, Vainchenker W, Hermine O, Solary E, Da Costa L; French Society of Hematology (SFH); French Society of Immunology and Hematology (SHIP).

Blood Adv. 2017 Oct 10;1(22):1959-1976. doi: 10.1182/bloodadvances.2017008078. eCollection 2017 Oct 10.

9.

Developmental differences between neonatal and adult human erythropoiesis.

Yan H, Hale J, Jaffray J, Li J, Wang Y, Huang Y, An X, Hillyer C, Wang N, Kinet S, Taylor N, Mohandas N, Narla A, Blanc L.

Am J Hematol. 2018 Aug;93(4):494-503. doi: 10.1002/ajh.25015. Epub 2018 Jan 9.

PMID:
29274096
10.

Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome.

Sakamoto KM, Narla A.

Leukemia. 2018 Feb;32(2):249-251. doi: 10.1038/leu.2017.314. Epub 2017 Sep 8. Review. No abstract available.

11.

Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.

Doulatov S, Vo LT, Macari ER, Wahlster L, Kinney MA, Taylor AM, Barragan J, Gupta M, McGrath K, Lee HY, Humphries JM, DeVine A, Narla A, Alter BP, Beggs AH, Agarwal S, Ebert BL, Gazda HT, Lodish HF, Sieff CA, Schlaeger TM, Zon LI, Daley GQ.

Sci Transl Med. 2017 Feb 8;9(376). pii: eaah5645. doi: 10.1126/scitranslmed.aah5645.

12.

Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors.

Youn M, Wang N, LaVasseur C, Bibikova E, Kam S, Glader B, Sakamoto KM, Narla A.

Haematologica. 2017 May;102(5):826-834. doi: 10.3324/haematol.2016.156257. Epub 2017 Feb 2.

13.

Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.

Dulmovits BM, Hom J, Narla A, Mohandas N, Blanc L.

Curr Opin Hematol. 2017 May;24(3):159-166. doi: 10.1097/MOH.0000000000000328. Review.

14.

Dyslipidemia in patients with chronic kidney disease.

Hager MR, Narla AD, Tannock LR.

Rev Endocr Metab Disord. 2017 Mar;18(1):29-40. doi: 10.1007/s11154-016-9402-z. Review.

PMID:
28000009
15.

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.

Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S, Uchida N, Hendel A, Narla A, Majeti R, Weinberg KI, Porteus MH.

Nature. 2016 Nov 17;539(7629):384-389. doi: 10.1038/nature20134. Epub 2016 Nov 7.

16.

Continuous Quantum Nondemolition Measurement of the Transverse Component of a Qubit.

Vool U, Shankar S, Mundhada SO, Ofek N, Narla A, Sliwa K, Zalys-Geller E, Liu Y, Frunzio L, Schoelkopf RJ, Girvin SM, Devoret MH.

Phys Rev Lett. 2016 Sep 23;117(13):133601. Epub 2016 Sep 19.

PMID:
27715126
17.

A novel pathogenic mutation in RPL11 identified in a patient diagnosed with diamond Blackfan anemia as a young adult.

Narla A, Yuan D, Kazerounian S, LaVasseur C, Ulirsch JC, Narla J, Glader B, Sankaran VG, Gazda H.

Blood Cells Mol Dis. 2016 Oct;61:46-7. doi: 10.1016/j.bcmd.2016.08.001. Epub 2016 Aug 17. No abstract available.

PMID:
27667165
18.

Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q- syndrome.

Narla A, Davis NL, Lavasseur C, Wong C, Glader B.

Am J Hematol. 2016 Dec;91(12):E501-E502. doi: 10.1002/ajh.24541. Epub 2016 Sep 30. No abstract available.

19.

The road not taken?

Narla A, Mohandas N.

Blood. 2016 Aug 18;128(7):886-8. doi: 10.1182/blood-2016-07-722413. No abstract available.

20.

Biology of the bone marrow microenvironment and myelodysplastic syndromes.

Rankin EB, Narla A, Park JK, Lin S, Sakamoto KM.

Mol Genet Metab. 2015 Sep-Oct;116(1-2):24-8. doi: 10.1016/j.ymgme.2015.07.004. Epub 2015 Jul 20. Review.

21.

Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes.

Huan J, Hornick NI, Goloviznina NA, Kamimae-Lanning AN, David LL, Wilmarth PA, Mori T, Chevillet JR, Narla A, Roberts CT Jr, Loriaux MM, Chang BH, Kurre P.

Leukemia. 2015 Dec;29(12):2285-95. doi: 10.1038/leu.2015.163. Epub 2015 Jun 25.

22.

Jekyll and Hyde: the role of heme oxygenase-1 in erythroid biology.

Narla A, Mohandas N.

Haematologica. 2015 May;100(5):567-8. doi: 10.3324/haematol.2015.124982. No abstract available.

23.

Quantum engineering. Confining the state of light to a quantum manifold by engineered two-photon loss.

Leghtas Z, Touzard S, Pop IM, Kou A, Vlastakis B, Petrenko A, Sliwa KM, Narla A, Shankar S, Hatridge MJ, Reagor M, Frunzio L, Schoelkopf RJ, Mirrahimi M, Devoret MH.

Science. 2015 Feb 20;347(6224):853-7. doi: 10.1126/science.aaa2085.

24.

TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors.

Bibikova E, Youn MY, Danilova N, Ono-Uruga Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S, Sakamoto KM.

Blood. 2014 Dec 11;124(25):3791-8. doi: 10.1182/blood-2014-06-584656. Epub 2014 Sep 30.

25.

L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way.

Narla A, Payne EM, Abayasekara N, Hurst SN, Raiser DM, Look AT, Berliner N, Ebert BL, Khanna-Gupta A.

Br J Haematol. 2014 Nov;167(4):524-528. doi: 10.1111/bjh.13069. Epub 2014 Aug 7.

26.

Tracking photon jumps with repeated quantum non-demolition parity measurements.

Sun L, Petrenko A, Leghtas Z, Vlastakis B, Kirchmair G, Sliwa KM, Narla A, Hatridge M, Shankar S, Blumoff J, Frunzio L, Mirrahimi M, Devoret MH, Schoelkopf RJ.

Nature. 2014 Jul 24;511(7510):444-8. doi: 10.1038/nature13436. Epub 2014 Jul 13.

PMID:
25043007
27.

Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.

Krönke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X, Ciarlo C, Hartman E, Munshi N, Schenone M, Schreiber SL, Carr SA, Ebert BL.

Science. 2014 Jan 17;343(6168):301-5. doi: 10.1126/science.1244851. Epub 2013 Nov 29.

28.

Autonomously stabilized entanglement between two superconducting quantum bits.

Shankar S, Hatridge M, Leghtas Z, Sliwa KM, Narla A, Vool U, Girvin SM, Frunzio L, Mirrahimi M, Devoret MH.

Nature. 2013 Dec 19;504(7480):419-22. doi: 10.1038/nature12802. Epub 2013 Nov 24.

PMID:
24270808
29.

Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome.

Vlachos A, Farrar JE, Atsidaftos E, Muir E, Narla A, Markello TC, Singh SA, Landowski M, Gazda HT, Blanc L, Liu JM, Ellis SR, Arceci RJ, Ebert BL, Bodine DM, Lipton JM.

Blood. 2013 Oct 3;122(14):2487-90. doi: 10.1182/blood-2013-06-509935. Epub 2013 Aug 13.

30.

The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders.

Raiser DM, Narla A, Ebert BL.

Leuk Lymphoma. 2014 Mar;55(3):491-500. doi: 10.3109/10428194.2013.812786. Epub 2013 Aug 28. Review.

PMID:
23863123
31.

Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts.

Shah DI, Takahashi-Makise N, Cooney JD, Li L, Schultz IJ, Pierce EL, Narla A, Seguin A, Hattangadi SM, Medlock AE, Langer NB, Dailey TA, Hurst SN, Faccenda D, Wiwczar JM, Heggers SK, Vogin G, Chen W, Chen C, Campagna DR, Brugnara C, Zhou Y, Ebert BL, Danial NN, Fleming MD, Ward DM, Campanella M, Dailey HA, Kaplan J, Paw BH.

Nature. 2012 Nov 22;491(7425):608-12. doi: 10.1038/nature11536. Epub 2012 Nov 7. Erratum in: Nature. 2013 Apr 18;496(7445):386.

32.

L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

Payne EM, Virgilio M, Narla A, Sun H, Levine M, Paw BH, Berliner N, Look AT, Ebert BL, Khanna-Gupta A.

Blood. 2012 Sep 13;120(11):2214-24. doi: 10.1182/blood-2011-10-382986. Epub 2012 Jun 25.

33.

Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet.

Renella R, Stickney C, Keswani M, Mancuso T, Casavant D, Ferguson M, Narla A.

Am J Hematol. 2012 Aug;87(8):816-8. doi: 10.1002/ajh.23166. Epub 2012 Mar 9. No abstract available.

34.

Translational medicine: ribosomopathies.

Narla A, Ebert BL.

Blood. 2011 Oct 20;118(16):4300-1. doi: 10.1182/blood-2011-08-372250. No abstract available.

35.

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.

Kumar MS, Narla A, Nonami A, Mullally A, Dimitrova N, Ball B, McAuley JR, Poveromo L, Kutok JL, Galili N, Raza A, Attar E, Gilliland DG, Jacks T, Ebert BL.

Blood. 2011 Oct 27;118(17):4666-73. doi: 10.1182/blood-2010-12-324715. Epub 2011 Aug 26.

36.

Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis.

Narla A, Dutt S, McAuley JR, Al-Shahrour F, Hurst S, McConkey M, Neuberg D, Ebert BL.

Blood. 2011 Aug 25;118(8):2296-304. doi: 10.1182/blood-2010-11-318543. Epub 2011 Apr 28.

37.

Diamond Blackfan anemia treatment: past, present, and future.

Narla A, Vlachos A, Nathan DG.

Semin Hematol. 2011 Apr;48(2):117-23. doi: 10.1053/j.seminhematol.2011.01.004. Review.

38.

Ribosome defects in disorders of erythropoiesis.

Narla A, Hurst SN, Ebert BL.

Int J Hematol. 2011 Feb;93(2):144-149. doi: 10.1007/s12185-011-0776-0. Epub 2011 Feb 1. Review.

39.

Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.

Al-Turkmani MR, Law T, Narla A, Kellogg MD.

Clin Chem. 2010 Dec;56(12):1792-4. doi: 10.1373/clinchem.2010.144824. No abstract available.

40.

Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges.

Lindamood KE, Fleck P, Narla A, Vergilio JA, Degar BA, Baldwin M, Wintermark P.

Am J Perinatol. 2011 May;28(5):337-46. doi: 10.1055/s-0030-1268710. Epub 2010 Nov 18.

PMID:
21089006
41.

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.

Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C, Wilson FH, Currie T, Khanna-Gupta A, Berliner N, Kutok JL, Ebert BL.

Blood. 2011 Mar 3;117(9):2567-76. doi: 10.1182/blood-2010-07-295238. Epub 2010 Nov 10.

42.

Ribosomopathies: human disorders of ribosome dysfunction.

Narla A, Ebert BL.

Blood. 2010 Apr 22;115(16):3196-205. doi: 10.1182/blood-2009-10-178129. Epub 2010 Mar 1. Review.

43.

Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.

Permaul P, Narla A, Hornick JL, Pai SY.

Immunol Res. 2009;44(1-3):89-98. doi: 10.1007/s12026-008-8085-2. Review.

PMID:
19225723
44.

Blood group antigens in health and disease.

Mohandas N, Narla A.

Curr Opin Hematol. 2005 Mar;12(2):135-40. Review.

PMID:
15725904

Supplemental Content

Support Center